hVIVO plc
OPORFOTCHealthcare● Active
$0.35
+$0.26(+306.50%)
Market Cap$240940378
P/E Ratio—
52W High$0.35
52W Low$0.0861
hVIVO plc (OPORF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OPORF · earnings · updated Jun 10, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 15, 2026EPS Actual
-$0.01
Revenue
$0.03B
Est. $0.06B · -49.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 15, 2026
After Market Close
▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
OPORF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 15, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | Apr 15, 2026 | — | -$0.01 | — | $0.03B | $0.06B | -49.1% |
| — Q2 FY2025 | Apr 7, 2025 | — | $0.01 | — | $0.03B | $0.03B | -3.1% |
| — Q3 FY2024 | Sep 10, 2024 | — | $0.01 | — | $0.05B | $0.05B | +4.6% |
| ▲ Q2 FY2024 | May 13, 2024 | $0.01 | $0.02 | +156.9% | $0.04B | $0.04B | +4.8% |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.01 | — | $0.03B | $0.04B | -5.1% |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.00 | — | $0.04B | $0.04B | +0.9% |
| — Q2 FY2022 | Jun 30, 2022 | — | $0.00 | — | $0.02B | — | — |
Q3 FY2026
Sep 15, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 15, 2026
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q2 FY2025
Apr 7, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q3 FY2024
Sep 10, 2024
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.05B
Q2 FY2024
May 13, 2024Beat
EPS Actual
$0.02
EPS Est.
$0.01
EPS Surpr.
+156.9%
Revenue
$0.04B
Q2 FY2023
Jun 30, 2023
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.04B
Q2 FY2022
Jun 30, 2022
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | Apr 15, 2026 | — | $0.09 | $0.09 | +0.00% |
| — Q2 FY2025 | Apr 7, 2025 | — | $0.24 | $0.24 | +0.00% |
| — Q3 FY2024 | Sep 10, 2024 | — | $0.35 | $0.35 | +0.00% |
| ▲ Q2 FY2024 | May 13, 2024 | +156.9% | $0.35 | $0.35 | +0.00% |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.15 | $0.15 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.10 | $0.10 | +0.00% |
| — Q2 FY2022 | Jun 30, 2022 | — | $0.23 | $0.23 | +0.00% |
| — Q4 FY2021 | Dec 31, 2021 | — | $0.26 | $0.26 | +0.00% |
Q2 FY2026+0.00%
Report Date
Apr 15, 2026
EPS Beat/Miss
—
Price Before
$0.09
Price After
$0.09
Q2 FY2025+0.00%
Report Date
Apr 7, 2025
EPS Beat/Miss
—
Price Before
$0.24
Price After
$0.24
Q3 FY2024+0.00%
Report Date
Sep 10, 2024
EPS Beat/Miss
—
Price Before
$0.35
Price After
$0.35
Q2 FY2024+0.00%
Report Date
May 13, 2024
EPS Beat/Miss
+156.9%
Price Before
$0.35
Price After
$0.35
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$0.15
Price After
$0.15
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.10
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$0.23
Price After
$0.23
Q4 FY2021+0.00%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$0.26
Price After
$0.26
Avg Beat Reaction+0.00%
Beat Rate1 / 8 quarters
Largest Move+0.00% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OPORF ends December
hVIVO plc (OPORF) most recently reported earnings on April 15, 2026 for Q2 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of —).
Each quarter, investors track OPORF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OPORF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OPORF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OPORF earnings · 4 questionshVIVO plc's next earnings report is expected around TBD. OPORF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OPORF historically reports after market close (AMC).
OPORF earnings datewhen is OPORF earningsOPORF next earnings datewhen does OPORF report earningsOPORF earnings calendar
▸ Source: FMP · hVIVO plc SEC filings · US GAAP · hVIVO plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026